Beruflich Dokumente
Kultur Dokumente
INTRODUCTION
The following table lists commercial fungicides according to their mode of action and resistance
risk. The most important bactericides are also included.
MOA Code
Different letters (A to I, with added numbers) were used to distinguish fungicide groups according
to their biochemical mode of action (MOA) in the biosynthetic pathways of plant pathogens. The
grouping was made according to processes in the metabolism starting from nucleic acids synthesis
(A) to secondary metabolism, e.g. melanin synthesis (I) at the end of the list, followed by host
plant defence inducers (P), recent molecules with an unknown mode of action and unknown
resistance risk (U, transient status, mostly not longer than 8 years, until information about mode of
action and mechanism of resistance becomes available), and multi-site inhibitors (M).
Group Name
The Group Names listed are based on chemical relatedness of structures which are accepted in
literature (e.g. The Pesticide Manual). They are based on different sources (chemical structure, site
of action, first important representative in group).
Chemical Group
Grouping is based on chemical considerations. Nomenclature according to IUPAC and Chemical
Abstract Name
Comments on Resistance
Details are given for the (molecular) mechanism of resistance and the resistance risk. If field
resistance is known to one member of the Group, it is most likely but not exclusively valid that
cross resistance to other group members will be present. There is increasing evidence that the
degree of cross resistance can differ between group members and pathogen species or even within
species. For the latest information on resistance and cross resistance status of a particular pathogen
/ fungicide combination, it is advised to contact local FRAC representatives, product
manufacturer’s representatives or crop protection advisors. The intrinsic risk for resistance
evolution to a given fungicide group is estimated to be low, medium or high according to the
principles described in FRAC Monographs 1, 2 and 3. Resistance management is driven by
intrinsic risk of fungicide, pathogen risk and agronomic risk (see FRAC pathogen risk list).
Similar classification lists of fungicides have been published by T. Locke on behalf of FRAG –
UK (Fungicide Resistance, August 2001), and by P. Leroux (Classification des fongicides
agricoles et résistance, Phytoma, La Défense des Végétaux, No. 554, 43-51, November 2002).
FRAC Code
Numbers and letters are used to distinguish the fungicide groups according to their cross resistance
behaviour. The numbers were assigned primarily according to the time of product introduction to
the market (numbers 1 to 43, status 2007). The letters refer to P = host plant defence inducers, M =
multi-site inhibitors, and U = unknown mode of action and unknown resistance risk.
* Copyright disclaimer
The FRAC Code List is the property of FRAC and protected by copyright laws. The FRAC Code
List may be used for educational purposes without permission from FRAC. Commercial use of this
material may only be made with the express, prior and written permission of FRAC.
benalaxyl
furalaxyl Resistance and cross
acylalanines metalaxyl resistance well known in
A1: metalaxyl-M various Oomycetes but
PA – fungicides (=mefenoxam) mechanism unknown. 4
RNA (PhenylAmides)
polymerase I oxazolidinones oxadixyl High risk. See FRAC
A: nucleic acids synthesis
Phenylamide Guidelines
butyrolactones ofurace for resistance management
C1:
complex I pyrimidinamines pyrimidinamines diflumetorim Resistance not known
39
NADH Oxido-
reductase
benodanil
phenyl-
flutolanil
benzamides
mepronil Resistance known for several
furan- fungal species in field 7
C2: fenfuram
carboxamides populations and lab mutants.
complex II: oxathiin- carboxin Target site mutations in sdh
succinate- carboxamides carboxamides oxycarboxin gene, e.g. H/Y (or H/L) at 257,
dehydro- thiazole- 267, 272 or P225L.
thifluzamide Medium risk. Resistance
genase carboxamides
pyrazole- furametpyr management required.
carboxamides penthiopyrad
pyridine-
boscalid
carboxamides
azoxystrobin
methoxy-
enestrobin
acrylates Resistance known in various
picoxystrobin
methoxy- fungal species. Target site
pyraclostrobin mutations in cyt b gene
C3: carbamates
oximino kresoxim-methyl (G143A, F129L) and additional
complex III: mechanisms.
cytochrome acetates trifloxystrobin
bc1 dimoxystrobin
QoI-fungicides oximino-
metominostrobin
C. respiration
(proposed) Anilinopyrimidine
(cgs gene) Guidelines
for resistance management.
D2: Low to medium risk.
enopyranuronic enopyranuronic
blasticidin-S Resistance management
protein acid antibiotic acid antibiotic 23
required.
synthesis
Resistance known in fungal
D3: and bacterial (P. glumae)
hexopyranosyl hexopyranosyl
kasugamycin pathogens. Medium risk.
protein antibiotic antibiotic
Resistance management
24
synthesis required.
D4: Bactericide. Resistance
glucopyranosyl glucopyranosyl known. High risk.
streptomycin
protein antibiotic antibiotic Resistance management 25
synthesis required.
D5:
Bactericide. Resistance
tetracycline tetracycline known. High risk.
protein oxytetracycline 41
antibiotic antibiotic Resistance management
synthesis
required.
E2:
Resistance found sporadically,
MAP/Histidine- PP-fungicides mechanism speculative.
fenpiclonil 12
Kinase in phenylpyrroles Low to medium risk.
(PhenylPyrroles) fludioxonil
osmotic signal Resistance management
transduction required.
(os-2, HOG1)
Resistance common in Botrytis
and some other pathogens.
Several mutations in OS-1,
E3: mostly I365S
chlozolinate
MAP/Histidine- iprodione Cross resistance common 2
Kinase in dicarboximides dicarboximides
procymidone between the group members.
osmotic signal vinclozolin
transduction Medium to high risk. See
(os-1, Daf1) FRAC Dicarboximide
Guidelines
for resistance management.
ferase
biphenyl
AH-fungicides
chloroneb
(Aromatic aromatic
F3: Hydrocarbons) hydrocarbons
dicloran Resistance known to some
quintozene (PCNB) fungi. Low to medium risk.
(chlorophenyls,
lipid tecnazene (TCNB) Cross resistance patterns
nitroanilines)
peroxidation tolclofos-methyl complex due to different 14
(proposed) activity spectra.
1,2,4-
heteroaromatics etridiazole
thiadiazoles
F4:
iodocarb Low to medium risk.
cell membrane carbamates carbamates propamocarb Resistance management 28
permeability, prothiocarb required.
fatty acids
(proposed)
cinnamic acid dimethomorph Resistance known in
F5: amides flumorph Plasmopara viticola but not in
benthiavalicarb Phytophthora infestans.
phospholipid CAA-fungicides valinamide Cross resistance between all 40
biosynthesis (Carboxylic Acid iprovalicarb
carbamates members of the CAA group.
and cell wall Amides) valiphenal
Low to medium risk. See
deposition mandelic acid
mandipropamid FRAC CAA Guidelines for
(proposed) amides resistance management
flutriafol
hexaconazole against the same fungus.
triazoles
imibenconazole
ipconazole DMI fungicides are Sterol
metconazole Biosynthesis Inhibitors (SBIs),
myclobutanil but show no cross resistance
penconazole to other SBI classes.
propiconazole
prothioconazole Medium risk. See FRAC SBI
simeconazole Guidelines
tebuconazole for resistance management.
tetraconazole
triadimefon
triadimenol
triticonazole
aldimorph Decreased sensitivity for
G2: dodemorph powdery mildews.
morpholines
fenpropimorph Cross resistance within the
Δ14-reductase Amines tridemorph group generally found but not
and (“Morpholines”) to other
Δ8→Δ7- fenpropidin 5
piperidines SBI classes.
isomerase piperalin
(SBI: Class II)
in sterol Low to medium risk. See
biosynthesis spiroketal- FRAC SBI Guidelines
spiroxamine
(erg24, erg2) amines for resistance management.
G3:
Low to medium risk.
3-keto reduc- hydroxyanilides
hydroxyanilides fenhexamid Resistance management 17
tase, C4- de- (SBI: Class III)
required.
methylation
(erg27)
G4: Resistance not known,
thiocarbamates pyributicarb fungicidal and herbicidal
squalene- activity 18
epoxidase in (SBI class IV)
sterol naftifine
biosynthesis allylamines Medical fungicides only
terbinafine
(erg1)
H3:
H: glucan synthesis
trehalase and
glucopyranosyl glucopyranosyl
validamycin Resistance not known 26
antibiotic antibiotic
inositol-
biosynthesis
furanone 16.1
(Melanin
pyrrolo- Resistance not known
reductase in Biosynthesis pyroquilon
quinolinone
melanin Inhibitors –
triazolobenzo-
cell wall
P1: benzo-
benzo-thiadiazole
thiadiazole acibenzolar-S-methyl Resistance not known
BTH
P: host plant defence
P4
natural compound laminarin Resistance unknown
(proposed)
phthalamic teclofthalam
unknown phthalamic acids Resistance not known
acids (Bactericide) 34
microtubule ethylamino-
thiazole
disruption
carboxamide
thiazole ethaboxam Resistance not known U5
(proposed) carboxamide
Resistance in Sphaerotheca.
phenyl-
unknown phenyl-acetamide
acetamide
cyflufenamid Resistance management U6
required
Resistance known. Medium
risk. Resistance management U7
required. Cross resistance to
quinoxyfen in Erysiphe
(Uncinula) necator but not in
unknown quinazolinone quinazolinone proquinazid
Blumeria graminis. As
precaution, proquinazid and
quinoxyfen should be
managed together for
resistance management
actin disruption
(proposed)
benzophenone benzophenone metrafenone Resistance not known U8
not classified